Back

Incident heart failure: comparing management and outcome in primary care and hospital settings in Western Sweden 2008-2017

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Outcomes in heart failure: a global perspective Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Xiaojing Chen

West China Hospital, Sichuan University, Chengdu (China)

8 More presentations in this session

Presentation thumbnail
Prognostic value of myocardial redox signalling: a machine learning multi-omics approach
Doctor I. Badi (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Protein signatures associated with methylation patterns of heart failure phenotypes
Mr M. Krolevets (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
20 year picture of a heart failure clinic: changes in the patients profiles' and 2-year mortality.
Miss A. Carrete (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
Temporal trends in clinical outcomes in heart failure patients with and without atrial fibrillation: a nationwide study from 1997-2018
Ms M. Austreim (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Temporal trends in treatment patterns, morbidity, and mortality in patients with new-onset heart failure compared to heart failure survivors: a nationwide 23-year perspective
Ms E. Boysen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes in heart failure: a global perspective

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Temporal trends in treatment patterns, morbidity, and mortality in patients with new-onset heart failure compared to heart failure survivors: a nationwide 23-year perspective
thumbnail
Congress Presentation
Characteristics of heart failure patients treated in primary care - a 20-year perspective of real-world data.
thumbnail
Congress Presentation
Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: Real-life data from the Swedish Heart Failure Registry 2013-2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources